RT @ZyVersaThera: Our CEO Mr. Glover comments on research published in Molecular Neurobiology which provides support for Inflammasome ASC I…
1,304 followers
2,222 followers
Our CEO Mr. Glover comments on research published in Molecular Neurobiology which provides support for Inflammasome ASC Inhibitor IC 100 as a potential therapeutic option for multiple sclerosis. To read the paper on IC 100 in an animal model of MS: https:/
187 followers
Desu, H.L., Plastini, M., Illiano, P. et al. IC100: a novel anti-ASC monoclonal antibody improves functional outcomes in an animal model of multiple sclerosis. J Neuroinflammation 17, 143 (2020). https://t.co/8wSCO4EG5B #DSFN5
12,926 followers
RT @Brandon_Beaber: A new class of multiple sclerosis drugs on the horizon? This study in mice shows that targeting the inflammasome adapt…